NZ315184A - Use of fluconazole for inhibiting the growth of cancers and viral infections - Google Patents

Use of fluconazole for inhibiting the growth of cancers and viral infections

Info

Publication number
NZ315184A
NZ315184A NZ315184A NZ31518496A NZ315184A NZ 315184 A NZ315184 A NZ 315184A NZ 315184 A NZ315184 A NZ 315184A NZ 31518496 A NZ31518496 A NZ 31518496A NZ 315184 A NZ315184 A NZ 315184A
Authority
NZ
New Zealand
Prior art keywords
fluconazole
viral infections
cancers
inhibiting
growth
Prior art date
Application number
NZ315184A
Other languages
English (en)
Inventor
James Berger Camden
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/674,180 external-priority patent/US5908855A/en
Application filed by Procter & Gamble filed Critical Procter & Gamble
Priority to NZ503921A priority Critical patent/NZ503921A/en
Publication of NZ315184A publication Critical patent/NZ315184A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NZ315184A 1995-08-04 1996-07-30 Use of fluconazole for inhibiting the growth of cancers and viral infections NZ315184A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ503921A NZ503921A (en) 1995-08-04 1996-07-30 Use of fluconazole mixed with chemotherapeutic agents for inhibiting the growth of cancers or tumors

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US188995P 1995-08-04 1995-08-04
US08/674,180 US5908855A (en) 1996-07-16 1996-07-16 Compositions for treating viral infections
PCT/US1996/012474 WO1997005873A2 (en) 1995-08-04 1996-07-30 Use of fluconazole for inhibiting the growth of cancers

Publications (1)

Publication Number Publication Date
NZ315184A true NZ315184A (en) 2000-05-26

Family

ID=26669622

Family Applications (2)

Application Number Title Priority Date Filing Date
NZ315184A NZ315184A (en) 1995-08-04 1996-07-30 Use of fluconazole for inhibiting the growth of cancers and viral infections
NZ503921A NZ503921A (en) 1995-08-04 1996-07-30 Use of fluconazole mixed with chemotherapeutic agents for inhibiting the growth of cancers or tumors

Family Applications After (1)

Application Number Title Priority Date Filing Date
NZ503921A NZ503921A (en) 1995-08-04 1996-07-30 Use of fluconazole mixed with chemotherapeutic agents for inhibiting the growth of cancers or tumors

Country Status (18)

Country Link
EP (1) EP0841921A2 (cs)
JP (1) JPH11510187A (cs)
KR (1) KR19990036138A (cs)
CN (1) CN1195288A (cs)
AR (1) AR003175A1 (cs)
AU (1) AU711966B2 (cs)
BR (1) BR9609966A (cs)
CA (1) CA2229024A1 (cs)
CZ (1) CZ33798A3 (cs)
HU (1) HUP9903420A3 (cs)
IL (1) IL123095A0 (cs)
MX (1) MX9800998A (cs)
NO (1) NO980473L (cs)
NZ (2) NZ315184A (cs)
PL (1) PL324904A1 (cs)
SK (1) SK14198A3 (cs)
TR (2) TR199800270T1 (cs)
WO (1) WO1997005873A2 (cs)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6177460B1 (en) 1995-04-12 2001-01-23 The Procter & Gamble Company Method of treatment for cancer or viral infections
US5770616A (en) 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US6686391B2 (en) 1995-08-04 2004-02-03 University Of Arizona Foundation N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
FR2742405B1 (fr) * 1995-12-13 1998-02-27 Cgea Comp Gen Entre Auto Unite motrice susceptible d'etre accouplee a une enceinte roulante et vehicule resultant
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
PE11499A1 (es) * 1997-05-16 1999-03-01 Procter & Gamble Tratamiento del hiv y cancer
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
DK2055313T3 (en) * 1998-11-09 2015-07-27 Biogen Inc Treatment of Hematologic Malignancies Related to Circulating Tumor Cells Using Chimeric Anti-CD20 Antibody
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US7004915B2 (en) * 2001-08-24 2006-02-28 Kci Licensing, Inc. Negative pressure assisted tissue treatment system
RU2201230C1 (ru) * 2001-12-24 2003-03-27 Закрытое акционерное общество "Брынцалов-А" Лекарственное средство флузол, обладающее противогрибковым действием
EP1895012A1 (en) 2006-08-30 2008-03-05 Universitätsklinikum Freiburg Method for inducing tumor apoptosis by increasing nitric oxide levels
WO2008073961A2 (en) * 2006-12-12 2008-06-19 Emory University Compounds and methods for modulating the silencing of a polynucleotide of interest
WO2019185521A1 (en) * 2018-03-26 2019-10-03 Westfälische Wilhelms-Universität Münster Ergosterol-biosynthesis inhibitor and influenza virus infection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0196855A3 (en) * 1985-03-29 1989-04-12 Pfizer Inc. Tioconazole and related compounds for prevention of sexually transmitted diseases and control of herpetic infections
BE1004029A6 (nl) * 1990-11-22 1992-09-08 Mol Omer De Farmaceutische samenstelling en farmaceutische set voor het behandelen van kanker.
US5565478A (en) * 1994-03-14 1996-10-15 The United States Of America As Represented By The Department Of Health & Human Services Combination therapy using signal transduction inhibitors with paclitaxel and other taxane analogs
US5665751A (en) * 1995-06-07 1997-09-09 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers

Also Published As

Publication number Publication date
IL123095A0 (en) 1998-09-24
NZ503921A (en) 2002-03-01
NO980473L (no) 1998-04-03
CZ33798A3 (cs) 1998-06-17
JPH11510187A (ja) 1999-09-07
WO1997005873A3 (en) 1997-03-27
EP0841921A2 (en) 1998-05-20
KR19990036138A (ko) 1999-05-25
HUP9903420A3 (en) 2001-12-28
TR199800270T1 (xx) 1998-05-21
NO980473D0 (no) 1998-02-03
AR003175A1 (es) 1998-07-08
SK14198A3 (en) 1999-03-12
WO1997005873A2 (en) 1997-02-20
BR9609966A (pt) 1999-02-02
AU6683396A (en) 1997-03-05
TR199801739T2 (xx) 1998-12-21
CN1195288A (zh) 1998-10-07
MX9800998A (es) 1998-04-30
PL324904A1 (en) 1998-06-22
AU711966B2 (en) 1999-10-28
CA2229024A1 (en) 1997-02-20
HUP9903420A2 (hu) 2000-03-28

Similar Documents

Publication Publication Date Title
NZ315184A (en) Use of fluconazole for inhibiting the growth of cancers and viral infections
YU68199A (sh) Farmaceutske formulacije koje sadrže vorikonazol
MX9605023A (es) Compuestos substituidos de imidazolidin-2,4-diona como substancias farmaceuticamente activas.
IL125282A (en) Substituted imidazole compounds, process for their preparation, pharmaceutical compositions containing them and use thereof in the preparation of medicaments for treating cytokine mediated diseases
MY131696A (en) 5-(2-imidazolinylamino) benzimidazole compounds useful as alpha-2 adrenoceptor agonists
MX9803792A (es) Inhibidor de proteina cinasa c.
DE60116761D1 (en) Adamantanderivate
MX9707431A (es) Inhibidores de la proteina cinasa c.
MX9702382A (es) Nuevos derivados de pirimidona con actividad antifungica.
BG101118A (en) Therapeutical compounds
HUP9802629A3 (en) Use of 1,3-bis(1,2,4-triazolyl)propan-2-ol derivatives for the manufacture of pharmaceutical compositions treating cancers
IL98399A0 (en) Process for foliar fungicide treatment and fungicide composition comprising a triazole derivative for implementing the process
IL117874A0 (en) Pharmaceutical compositions for inhibiting the growth of viruses and cancers
NZ308391A (en) Use of 1,2,4-triazole derivatives for the manufacture of a medicament for the treatment of cancers
DE69907419D1 (en) Antitumorwirkstoffe
ZA923940B (en) Substituted diaminophthalimides and analogues
IL123093A0 (en) Pharmaceutical compositions containing 1h-1,2,4-triazole derivatives for inhibiting the growth of cancers
WO2001066551A8 (en) Azole compounds as therapeutic agents for fungal infections
MX9709451A (es) Derivados de benzisoxazol e indazol como agentes antipsicoticos.
MY125854A (en) Crystal modification of 1-(2,6-difluorobenzyl)-1h-1,2,3-triazole-4-carboxamide
TR200401775T4 (tr) 3-Amino-1-Fenil-1H[1,2,4] triazol'ün dallanmış değiştirilmiş yeni amino türevleri, bunların imali için metot ve bunları içeren farmosötik (eczacılık) bileşimleri
MY107016A (en) Use of certain triazoles to protect materials from fungal attack, articles and compositions
YU46302A (sh) Supstituisani piroli
MY118946A (en) Novel intermediates and their use to prepare n, n''- bridged bisindolylmaleimides
BR0017046A (pt) Uso de azóis para prevenção de câncer de pele